• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sidoti Events, LLC's Virtual June Small-Cap Conference

    6/11/24 10:50:00 AM ET
    $AGI
    $ALUR
    $ATOS
    $BRC
    Precious Metals
    Basic Materials
    Medical/Dental Instruments
    Health Care
    Get the next $AGI alert in real time by email

    NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.

    Presentation Schedule

    *All Times EDT

    Wednesday, June 12, 2024 (Day 1)

    8:30-9:00

    *****

    *****

    InfuSystem Holdings Inc. (INFU)

    *****

    9:15-9:45

    *****

    ECD Automotive (ECDA)

    Lifeward [ReWalk Robotics] (LFWD)

    *****

    10:00-10:30

    Unisys Corporation (UIS)

    *****

    Myomo, Inc (MYO)

    Drilling Tools International Corp. (DTI)

    10:45-11:15

    American Software (AMSWA)

    USANA Health Sciences (USNA)

    Assertio Holdings, Inc. (ASRT)

    Information Services Group ["ISG"] (III)

    11:30-12:00

    Vishay Precision Group (VPG)

    Global Industrial Company (GIC)

    Zomedica Corp. (ZOM)

    Charles River Associates (CRAI)

    12:15-12:45

    Quad/Graphics Inc (QUAD)

    *****

    RadNet, Inc. (RDNT)

    *****

    1:00-1:30

    *****

    Rayonier Advanced Materials ["RYAM"] (RYAM)

    Superior Group of Companies (SGC)

    Portman Ridge Finance Corp (PTMN)

    1:45-2:15

    *****

    Electromed (ELMD)

    Senseonics Holdings, Inc. (SENS)

    BioLargo, Inc. (BLGO)

    2:30-3:00

    A10 Networks, Inc. (ATEN)

    Granite Ridge Resources, Inc. (GRNT)

    Theravance Biopharma (TBPH)

    ARC Document Solutions (ARC)

    3:15-3:45

    GlucoTrack Inc. (GCTK)

    Canoo (GOEV)

    Bitcoin Depot (BTM)

    Topaz Energy Corp (TSX:TPZ)

    4:00-4:30

    Intelligent Bio Solutions (INBS)

    Brilliant Earth Group, Inc. (BRLT)

    Oportun Financial Corp. (OPRT)

    TrueBlue (TBI)

    1x1s Only

    (12th)

    GATX Corporation (GATX)

    Hillenbrand (HI)

    MYR Group Inc. (MYRG)

    Pitney Bowes (PBI)

    Primoris Services Corporation (PRIM)

    Sonendo (SONX)

    Titan International, Inc. (TWI)

    *****

    *All Times EDT

    Thursday, June 13, 2024 (Day 2)

    8:30-9:00

    GDEV Inc. (GDEV)

    *****

    Meihua Intl. Medical Technologies Co. (MHUA)

    *****

    9:15-9:45

    Commercial Vehicle Group (CVGI)

    Atossa Therapeutics (ATOS)

    Citius Pharmaceuticals, Inc. (CTXR)

    *****

    10:00-10:30

    Paysign, Inc. (PAYS)

    Graham Corporation (GHM)

    Allurion (ALUR)

    Mobile Infrastructure (BEEP)

    10:45-11:15

    *****

    Genco Shipping & Trading Ltd (GNK)

    VAREX IMAGING (VREX)

    Nature's Sunshine (NATR)

    11:30-12:00

    *****

    Brady Corporation (BRC)

    BioHarvest Sciences Inc. (CNVCD)

    Hovnanian Enterprises Inc (HOV)

    12:15-12:45

    *****

    Great Lakes Dredge & Dock Corp. (GLDD)

    *****

    CES Energy Solutions (CEU-TSX)

    1:00-1:30

    Sonim Technologies Inc. (SONM)

    Amerigo Resources (ARREF)

    *****

    The Real Brokerage Inc (REAX)

    1:45-2:15

    *****

    NN Inc. (NNBR)

    *****

    Consumer Portfolio Services (CPSS)

    2:30-3:00

    *****

    Alamos Gold Inc. (AGI)

    GoHealth (GOCO)

    Resources Connection, Inc. (RGP)

    1x1s Only

    (13th)

    Belden Inc. (BDC)

    CSW Industrials (CSWI)

    Federal Signal Corporation (FSS)

    HNI Corporation (HNI)

    OneSpan Inc. (OSPN)

    Plexus Corp. (PLXS)

    Sonendo (SONX)

    *****

    About Sidoti Events, LLC ("Events") and Sidoti & Company, LLC ("Sidoti")
    In 2023, Sidoti & Company, LLC (www.sidoti.com) formed an affiliate company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the 25 years of experience Sidoti has as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises approximately 150 equities of which greater than 60 percent participate in the firm's rapidly growing Company Sponsored Research ("CSR") program. In 2024, Sidoti established Lighthouse Equity Research as an extension of its CSR program to meet the specific needs of companies not valued using traditional metrics or that face challenges obtaining coverage due to political risks or other factors. Events is a leading provider of corporate access through the eight investor conferences it hosts each year. By virtue of its direct ties to Sidoti, Event's benefits from Sidoti's small- and microcap-focused nationwide sales force, which has connections with 2,500 institutional relationships in North America. This enables Events to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.

    SOURCE: Sidoti Events, LLC



    View the original press release on accesswire.com

    Get the next $AGI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGI
    $ALUR
    $ATOS
    $BRC

    CompanyDatePrice TargetRatingAnalyst
    Alamos Gold Inc.
    $AGI
    11/28/2025Buy
    Desjardins
    GoHealth Inc.
    $GOCO
    11/19/2025Outperform → Mkt Perform
    William Blair
    Plexus Corp.
    $PLXS
    10/24/2025$150.00Buy → Neutral
    Sidoti
    Graham Corporation
    $GHM
    10/21/2025Outperform → Market Perform
    Noble Capital Markets
    NN Inc.
    $NNBR
    7/31/2025$4.00Buy
    B. Riley Securities
    Plexus Corp.
    $PLXS
    7/25/2025$150.00Neutral → Buy
    Sidoti
    Alamos Gold Inc.
    $AGI
    7/9/2025Buy
    Stifel
    Graham Corporation
    $GHM
    7/2/2025$65.00Buy
    Maxim Group
    More analyst ratings

    $AGI
    $ALUR
    $ATOS
    $BRC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim

    Partnership expands access to LYMPHIR for patients with cutaneous T-cell lymphoma across Turkey, Bahrain, Qatar, Oman, Kuwait, Saudi Arabia, and the UAE LYMPHIR international availability extends to 19 markets outside the U.S. CRANFORD, N.J., Dec. 4, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (NASDAQ:CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (NASDAQ:CTXR), today announced that it has entered into an exclusive distribution agreement with Er-Kim İlaç Sanayi ve Ticaret A.Ş. ("Er-Kim"), a leading pharmaceutical distributor based in Turkey, for LYMPHIR (denileukin diftitox-cxdl), a novel IL-2 receptor-directed cytotoxin, approved

    12/4/25 8:37:00 AM ET
    $CTOR
    $CTXR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Atossa Therapeutics Details Accelerated FDA Strategy to Advance (Z)-Endoxifen Across Breast Cancer Continuum

    Company positioned to pursue expedited regulatory pathways in metastatic, neoadjuvant, and risk-reduction settings SEATTLE, Dec. 4, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company focused on transforming breast cancer treatment and prevention, announced the completion of a Type C meeting with the U.S. Food and Drug Administration ("FDA") on November 17, 2025, to review regulatory strategy for advancing (Z)-endoxifen. During the meeting, the FDA provided the Company feedback on potential expedited regulatory pathways and development options across metastatic disease, neoadjuvant treatment, and breast cancer r

    12/4/25 8:00:00 AM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Brady Corporation elects Board of Directors and declares regular dividend to shareholders

    MILWAUKEE, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE:BRC) ("Company") announced that shareholders of the Company's Class B Common Voting Stock have voted unanimously in favor of the election of the director nominees to a one-year term at the Company's annual meeting of shareholders held today in Milwaukee. Elected to the Brady Corporation Board of Directors are: Patrick W. Allender, Executive Vice President and Chief Financial Officer (Retired), Danaher CorporationDr. David S. Bem, Vice President of Science and Technology and Chief Technology Officer, PPG Industries, Inc.Dr. Elizabeth P. Bruno, President, Brady Education FoundationJoanne Collins Smee, Executive Vice Pre

    12/3/25 5:10:00 PM ET
    $BRC
    Miscellaneous manufacturing industries
    Consumer Discretionary

    $AGI
    $ALUR
    $ATOS
    $BRC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gregorio Mauro bought $58,812 worth of shares (1,200 units at $49.01) (SEC Form 4)

    4 - GRAHAM CORP (0000716314) (Issuer)

    9/15/25 4:26:30 PM ET
    $GHM
    Industrial Machinery/Components
    Industrials

    President & CEO Quay Steven C bought $9,887 worth of shares (11,239 units at $0.88), increasing direct ownership by 423% to 13,898 units (SEC Form 4)

    4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)

    5/22/25 6:27:25 PM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Gaur Shantanu bought $24,484 worth of shares (8,000 units at $3.06), increasing direct ownership by 100% to 16,000 units (SEC Form 4)

    4 - ALLURION TECHNOLOGIES, INC. (0001964979) (Issuer)

    5/21/25 4:15:08 PM ET
    $ALUR
    Medical/Dental Instruments
    Health Care

    $AGI
    $ALUR
    $ATOS
    $BRC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP-Project Acquisition & Ops Johanson David sold $130,155 worth of shares (10,000 units at $13.02), decreasing direct ownership by 10% to 94,063 units (SEC Form 4)

    4 - Great Lakes Dredge & Dock CORP (0001372020) (Issuer)

    12/4/25 5:17:13 PM ET
    $GLDD
    Military/Government/Technical
    Industrials

    Director Rapp Karen Marie sold $71,735 worth of shares (500 units at $143.47), decreasing direct ownership by 6% to 7,665 units (SEC Form 4)

    4 - PLEXUS CORP (0000785786) (Issuer)

    12/2/25 4:35:08 PM ET
    $PLXS
    Electrical Products
    Technology

    Exec VP, CAO, Gen Coun & Secy Ninivaggi Angelo Michael Jr sold $195,222 worth of shares (1,347 units at $144.93), decreasing direct ownership by 6% to 21,544 units (SEC Form 4)

    4 - PLEXUS CORP (0000785786) (Issuer)

    11/28/25 4:48:21 PM ET
    $PLXS
    Electrical Products
    Technology

    $AGI
    $ALUR
    $ATOS
    $BRC
    SEC Filings

    View All

    $AGI
    $ALUR
    $ATOS
    $BRC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Atossa Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ATOSSA THERAPEUTICS, INC. (0001488039) (Filer)

    12/4/25 8:15:24 AM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Brady Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - BRADY CORP (0000746598) (Filer)

    12/3/25 5:11:46 PM ET
    $BRC
    Miscellaneous manufacturing industries
    Consumer Discretionary

    SEC Form 144 filed by Allurion Technologies Inc.

    144 - ALLURION TECHNOLOGIES, INC. (0001964979) (Subject)

    12/2/25 3:56:15 PM ET
    $ALUR
    Medical/Dental Instruments
    Health Care

    Desjardins initiated coverage on Alamos

    Desjardins initiated coverage of Alamos with a rating of Buy

    11/28/25 7:19:36 AM ET
    $AGI
    Precious Metals
    Basic Materials

    GoHealth downgraded by William Blair

    William Blair downgraded GoHealth from Outperform to Mkt Perform

    11/19/25 8:54:30 AM ET
    $GOCO
    Specialty Insurers
    Finance

    Plexus downgraded by Sidoti with a new price target

    Sidoti downgraded Plexus from Buy to Neutral and set a new price target of $150.00

    10/24/25 8:46:54 AM ET
    $PLXS
    Electrical Products
    Technology

    $AGI
    $ALUR
    $ATOS
    $BRC
    Financials

    Live finance-specific insights

    View All

    Brady Corporation elects Board of Directors and declares regular dividend to shareholders

    MILWAUKEE, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE:BRC) ("Company") announced that shareholders of the Company's Class B Common Voting Stock have voted unanimously in favor of the election of the director nominees to a one-year term at the Company's annual meeting of shareholders held today in Milwaukee. Elected to the Brady Corporation Board of Directors are: Patrick W. Allender, Executive Vice President and Chief Financial Officer (Retired), Danaher CorporationDr. David S. Bem, Vice President of Science and Technology and Chief Technology Officer, PPG Industries, Inc.Dr. Elizabeth P. Bruno, President, Brady Education FoundationJoanne Collins Smee, Executive Vice Pre

    12/3/25 5:10:00 PM ET
    $BRC
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Genco Shipping & Trading to Acquire Two High-Specification Newcastlemax Vessels

    NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Genco Shipping & Trading Limited (NYSE:GNK) ("Genco" or the "Company"), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, has agreed to acquire two 2020-built 208,000 dwt scrubber fitted Newcastlemax vessels for a total purchase price of $145.5 million. Genco expects to take delivery of the vessels during the first quarter of 2026 and intends to fund the acquisition with cash on hand and a drawdown from its revolving credit facility. John C. Wobensmith, Chairman and Chief Executive Officer, commented, "We are pleased to acquire two more high quality, premium earning vessels, underscoring Genco

    11/19/25 4:15:00 PM ET
    $GNK
    Marine Transportation
    Consumer Discretionary

    Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2025

    Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the fourth quarter and fiscal year 2025. Q4FY25 Summary Revenues $229 million GAAP gross margin 34% | Non-GAAP gross margin* 34% GAAP operating margin 9% | Non-GAAP operating margin* 10% GAAP net income $0.29 per diluted share | Non-GAAP net income* $0.37 per diluted share Cash flow from operations was $8 million FY25 Summary Revenues $845 million GAAP gross margin 34% | Non-GAAP gross margin* 35% GAAP operating margin (3)% | Non-GAAP operating margin* 9% GAAP net loss $(1.70) per diluted share | Non-GAAP net income* $0.90 per diluted share Cash flow from operations

    11/18/25 4:05:00 PM ET
    $VREX
    Industrial Machinery/Components
    Technology

    $AGI
    $ALUR
    $ATOS
    $BRC
    Leadership Updates

    Live Leadership Updates

    View All

    Atossa Appoints Mark Daniel, CPA, as Chief Financial Officer to Lead Finance, Systems, and Capital Strategy for Commercial Readiness

    25+ year life-sciences finance leader brings revenue-forecasting rigor, public-company controls, and capital-markets experience as Atossa prepares for commercial operations with (Z)-endoxifen SEATTLE, Oct. 14, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing new approaches in breast cancer treatment and prevention, announces the appointment of Mark Daniel, CPA (WA; inactive), as Chief Financial Officer. Mr. Daniel is a senior finance leader with more than 25 years of experience building the forecasting cadence, systems, and public-company discipline that support revenue scale in global life-science

    10/14/25 8:00:00 AM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NN, Inc. Appoints Gregg Cottage as Chief Information Officer and CISO

    CHARLOTTE, N.C., Oct. 01, 2025 (GLOBE NEWSWIRE) -- NN, Inc. (NASDAQ:NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, has announced the promotion of Gregg Cottage to serve as its new Chief Information Officer and Chief Information Security Officer. In this position, Mr. Cottage leads the Company's information technology function, including its enterprise information security strategy. Mr. Cottage will report to Chris Bohnert, Senior Vice President and Chief Financial Officer. Chris Bohnert, Senior Vice President and Chief Financial Officer of NN, commented, "We are pleased to announce Gregg's promotion, which will help

    10/1/25 4:15:00 PM ET
    $NNBR
    Industrial Machinery/Components
    Industrials

    Atossa Therapeutics Names Janet R. Rea, MSPH, as Senior Vice President, R&D to Accelerate (Z)-Endoxifen Toward Key Regulatory Milestones

    Veteran development leader with successful regulatory approvals record returns to lead late-stage clinical and regulatory programs to address multiple unmet clinical needs SEATTLE, Oct. 1, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS, ", Atossa", or the ", Company", )), a clinical-stage biopharmaceutical company developing new approaches in breast cancer treatment and prevention, announces the appointment of Janet R. Rea, MSPH to its newly created position Senior Vice President, R&D.  Ms. Rea brings more than two decades of strategic research and clinical development expertise, with a success record for regulatory approvals, to oversee late-stage (Z)-endoxifen programs with ne

    10/1/25 8:30:00 AM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGI
    $ALUR
    $ATOS
    $BRC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Citius Pharmaceuticals Inc.

    SC 13D/A - Citius Pharmaceuticals, Inc. (0001506251) (Subject)

    11/27/24 4:05:31 PM ET
    $CTXR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Meihua International Medical Technologies Co. Ltd.

    SC 13G - Meihua International Medical Technologies Co., Ltd. (0001835615) (Subject)

    11/14/24 6:08:55 PM ET
    $MHUA
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Allurion Technologies Inc.

    SC 13G/A - ALLURION TECHNOLOGIES, INC. (0001964979) (Subject)

    11/14/24 4:43:43 PM ET
    $ALUR
    Medical/Dental Instruments
    Health Care